Integrating the Future & the Present (Authentise Weekly 3D News Review – Week 51)

Hi all, welcome to another (festive!) edition of the weekly review by Authentise!

We hope you had a merry Christmas time! As we go back to our usual day-to-day, we gathered last week’s juiciest 3D news. Many companies are tackling the issues of integrating their work on new tech into present standards and workflows. Sounds like Organovo’s work on pre-clinical bioprinting is finally getting there, Oas are standards for AM enabled medical. Other times industrialization doesnt need to be so complicated: IIoT allows smaller, incremental steps to be taken to integrate new tech and practices to benefit businesses.

Let’s dig in.

Organovo 3D bioprinted liver tissue could make it to the FDA by 2019

Speculation on 3D printed tissue coming to humans sooner than we think is backed by new pre-clinical findings from 3D bioprinting company Organovo. Though it will still be 3–5 years before the U.S. based Organovo apply for clearance of their liver tissue, that is still sooner than perhaps even the FDA had in mind. Pre-clinical trial data shows that 3D bioprinted liver tissue has been successfully planted into lab-bred mice. The human liver-cell tissue shows regular functionality and, at this stage, is being explored as a suitable patch for the organ.

Read more at 3D Printing Industry.

3D Printing Production Medical Devices — Pitfalls And Best Practices

In May 2016, the FDA released a draft guidance titled Technical Considerations for Additive Manufactured Devices. Any manufacturer or organization considering 3D-printed components during the development of a medical device should refer to this document. The guidance goes into detail regarding risk and other considerations related to 3D printing, as well as how to employ 3D printing within device development.

Read the article here and the FDA guidance here.

Use Existing Data to Optimize IIoT Sensor Deployment

It is hard to know where to start [in IIoT], and whether the solution being designed will be palatable to the end customer in terms of function and price. Rather than ordering highly marketed solutions from outside the enterprise and “tipping” consultants with exorbitant fees, they can find ingredients that are already on hand, apply basic analytics, and come up with some surprisingly tasty ways to translate raw data into process information to improve maintenance or business decisions.

Read about the useful, and easy, ways IIoT can easily be integrated in your business here.

We hope to see you next week for another edition brought to you by Authentise!

#clinical #bioprinting #2019 #IIoT #guidance #FDA #Organovo #liver #medical #analytics #guidelines #devices

Follow us at:

  • LinkedIn
  • Twitter
  • YouTube
  • Facebook

MES for OEMs

MES for Service Bureaus

Extension Modules

About

Company Overview

Jobs

Support

Resources

Machine Integrations

Software Integrations

Contact Us

Philadelphia, PA, USA

Member of

Privacy Policy

Terms of Use

AUTHENTISE © COPYRIGHT 2020. ALL RIGHTS RESERVED.